Tissue-specific/JJ
regulation/NN
of/IN
the/DT
ecto-5'-nucleotidase/JJ|NN
promoter/NN
./.
=====
Role/NN
of/IN
the/DT
camp/NN
response/NN
element/NN
site/NN
in/IN
mediating/VBG
repression/NN
by/IN
the/DT
upstream/JJ
regulatory/JJ
region/NN
./.

We/PRP
have/VBP
isolated/VBN
the/DT
5'/JJ
region/NN
of/IN
the/DT
ecto-5'-nucleotidase/JJ
(/(
low/JJ
K/NN
(/(
m/NN
)/)
5'-NT/JJ|NN
)/)
gene/NN
and/CC
established/VBD
that/IN
a/DT
969-base/JJ
pair/NN
(/(
bp/NN
)/)
fragment/NN
confers/VBZ
cell-specific/JJ
expression/NN
of/IN
a/DT
CAT/NN
reporter/NN
gene/NN
that/WDT
correlates/VBZ
with/IN
the/DT
expression/NN
of/IN
endogenous/JJ
ecto-5'-NT/JJ|NN
mRNA/NN
and/CC
enzymatic/JJ
activity/NN
./.
=====
A/DT
768-bp/JJ
upstream/JJ
negative/JJ
regulatory/JJ
region/NN
has/VBZ
been/VBN
identified/VBN
that/WDT
conferred/VBD
lymphocyte-specific/JJ
negative/JJ
regulation/NN
in/IN
a/DT
heterologous/JJ
system/NN
with/IN
a/DT
244-bp/JJ
deoxycytidine/NN
kinase/NN
core/NN
promoter/NN
./.
=====
DNase/NN
I/CD
footprinting/NN
identified/VBD
several/JJ
protected/JJ
areas/NNS
including/VBG
Sp1/NN
,/,
Sp1/AP-2/NN
,/,
and/CC
cAMP/NN
response/NN
element/NN
(/(
CRE/NN
)/)
binding/NN
sites/NNS
within/IN
the/DT
201-bp/JJ
core/NN
promoter/NN
region/NN
and/CC
Sp1/NN
,/,
NRE-2a/NN
,/,
TCF-1/LEF-1/NN
,/,
and/CC
Sp1/NF-AT/NN
binding/NN
sites/NNS
in/IN
the/DT
upstream/JJ
regulatory/JJ
region/NN
./.
=====
Whereas/IN
the/DT
CRE/NN
site/NN
was/VBD
essential/JJ
in/IN
mediating/VBG
the/DT
negative/JJ
activity/NN
of/IN
the/DT
upstream/JJ
regulatory/JJ
region/NN
in/IN
Jurkat/NN
but/CC
not/RB
in/IN
HeLa/NN
cells/NNS
,/,
mutation/NN
of/IN
the/DT
Sp1/AP-2/NN
site/NN
decreased/VBD
promoter/NN
activity/NN
in/IN
both/DT
cell/NN
lines/NNS
./.
=====
Electrophoretic/JJ
mobility/NN
shift/NN
assay/NN
analysis/NN
of/IN
proteins/NNS
binding/VBG
to/TO
the/DT
CRE/NN
site/NN
identified/VBD
both/CC
ATF-1/NN
and/CC
ATF-2/NN
in/IN
Jurkat/NN
cells/NNS
./.
=====
Finally/RB
,/,
phorbol/NN
12-myristate/NN
13-acetate/NN
increased/VBD
the/DT
activity/NN
of/IN
both/CC
the/DT
core/NN
and/CC
the/DT
969-bp/JJ
promoter/NN
fragments/NNS
,/,
and/CC
this/DT
increase/NN
was/VBD
abrogated/VBN
by/IN
mutations/NNS
at/IN
the/DT
CRE/NN
site/NN
./.
=====
In/IN
summary/NN
,/,
we/PRP
have/VBP
identified/VBN
a/DT
tissue-specific/JJ
regulatory/JJ
region/NN
5'/JJ
of/IN
the/DT
ecto-5'-NT/JJ|NN
core/NN
promoter/NN
that/WDT
requires/VBZ
the/DT
presence/NN
of/IN
a/DT
functional/JJ
CRE/NN
site/NN
within/IN
the/DT
basal/JJ
promoter/NN
for/IN
its/PRP$
suppressive/JJ
activity/NN
./.